Greenland Mines Ltd Advances Critical Minerals Projects in Greenland, Targeting Western Supply Chain Independence
Found this article helpful?
Share it with your network and spread the knowledge!
Greenland Mines Ltd (NASDAQ: GRML) is strengthening its position in the critical minerals sector by advancing its Skaergaard palladium-gold-platinum project in Greenland and pursuing the acquisition of the Sarfartoq neodymium-praseodymium (NdPr) rare-earths project. These developments come as Western governments and industries seek alternatives to Chinese and Russian supply sources for strategically important minerals.
The Skaergaard project hosts a substantial palladium-equivalent resource, with an NI 43-101 Mineral Resource of 11.4 million ounces PdEq indicated and 14.1 million ounces PdEq inferred. An independent sensitivity study by SLR Consulting recently demonstrated significant metal-price leverage for the project. While these resources are not yet proven economically viable, the company has not completed a preliminary economic assessment or feasibility study.
Greenland Mines plans to add the Sarfartoq rare-earth project to its portfolio through a previously announced transaction. This acquisition would establish Neo Performance Materials as a strategic shareholder and future offtake partner, providing a pathway for downstream processing of rare-earth elements critical for permanent magnets used in electric vehicles and wind turbines.
The company joins a group of firms focused on strengthening Western critical minerals supply chains, including Platinum Group Metals Ltd. (NYSE American: PLG; TSX: PTM), Valterra Platinum Limited (JSE: VAL; OTC: ANGPY), Aclara Resources Inc. (TSX: ARA), and The Metals Company (NASDAQ: TMC). Greenland Mines’ unique position across both platinum-group metals and rare earths in a Western-aligned jurisdiction offers exposure to two mineral markets that have become increasingly important to governments, manufacturers, and investors.
The full press release can be accessed at https://ibn.fm/kPV46. Greenland Mines Ltd is Nasdaq-listed with two operating divisions: mining, focused on the Skaergaard and Sarfartoq projects, and biotech, including Klotho’s KLTO-202 primary indication for ALS. The company is led by an experienced team of mining, geological, biotech, and capital markets professionals. More information is available at https://greenlandmines.com/.